Northwestern Medicine Cancer Center Delnor — Geneva, Illinois

Public research footprint of Northwestern Medicine Cancer Center Delnor, compiled from the ClinicalTrials.gov public registry.

232

Registered studies

176

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Platinum-Resistant Fallopian Tube Carcinoma · Recurrent Platinum-Resistant Primary Peritoneal Carcinoma · Recurrent Platinum-Resistant Ovarian Carcinoma · Metastatic Non-Cutaneous Melanoma

Recently updated registry entries

NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)
NCT04739800 — Comparison of Standard of Care Treatment With a Triplet Combination of Targeted… (Active Not Recruiting)
NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Northwestern Medicine Cancer Center Delnor?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.